The first quarterly All Member Meeting of 2020 is taking place on Wednesday 22nd January 2020, from 10am to 1pm in the Allen Room at St...

Rapid Diagnostic Centres (RDCs) and the roll out of personalised care are cornerstones of the implementation plans for Cancer Alliances...

The annual All Stakeholder Briefing was a great success and we had a good turnout of both member organisations and pharmaceutical...

On Wednesday 10th July we launched a new report, ‘Getting a better deal for people with rare and less common cancers: what we can learn...

Cancer52 held a roundtable on 4th April 2019 to explore the implications of the NHS Long Term Plan and what it means for rare and less...

The All Member Meeting featured a great mix of speakers - Jess Mills of Act for Cancer; and Mary-Jo Pryor of NHSE Specialised...

Slides from the recent Briefing on the 2019 Voluntary Scheme for Branded Medicines from the Association of the British Pharmaceutical...

It was great to see some of you at the Britain Against Cancer conference on 4 December and thank you to those of you – or your patients -...

When a person is diagnosed with cancer in the UK information about them is automatically included in their national cancer registry. It...

The annual All Stakeholder Briefing was held on 17 October 2018. We were honoured that Cally Palmer, National Cancer Director, NHS...